Viral bronchiolitis is the most common cause of admission to hospital for infants in high-
income countries. Respiratory syncytial virus accounts for 60–80% of bronchiolitis …

Viral bronchiolitis is a common clinical syndrome affecting infants and young children.
Concern about its associated morbidity and cost has led to a large body of research that has …

This guideline is a revision of the clinical practice guideline,“Diagnosis and Management of
Bronchiolitis,” published by the American Academy of Pediatrics in 2006. The guideline …

Respiratory syncytial virus (RSV) is amongst the most important pathogenic infections of
childhood and is associated with significant morbidity and mortality. Although there have …

2. Although the quest for a safe and effective vaccine remains unsuccessful, the more
vulnerable patients can be protected with passive prophylaxis. Because of limited clinical …

Background Specific treatments for influenza are limited to neuraminidase inhibitors and
adamantanes. Corticosteroids show evidence of benefit in sepsis and related conditions …

In global terms, respiratory viral infection is a major cause of morbidity and mortality. Infancy,
in particular, is a time of increased disease susceptibility and severity. Early-life viral …

Respiratory syncytial virus (RSV) is a major worldwide cause of morbidity and mortality in
children under five years of age. Evidence-based management guidelines suggest that …

The global burden of respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI)
in young children is high. The RSV prevention strategies approved in 2023 will be essential …

Human respiratory syncytial virus (RSV) is a ubiquitous pathogen that infects everyone
worldwide early in life and is a leading cause of severe lower respiratory tract disease in the …